125 related articles for article (PubMed ID: 24618835)
1. Calycosin suppresses breast cancer cell growth via ERβ-dependent regulation of IGF-1R, p38 MAPK and PI3K/Akt pathways.
Chen J; Hou R; Zhang X; Ye Y; Wang Y; Tian J
PLoS One; 2014; 9(3):e91245. PubMed ID: 24618835
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways.
Vanamala J; Reddivari L; Radhakrishnan S; Tarver C
BMC Cancer; 2010 May; 10():238. PubMed ID: 20504360
[TBL] [Abstract][Full Text] [Related]
3. Protein arginine N-methyltransferase 2 reverses tamoxifen resistance in breast cancer cells through suppression of ER-α36.
Shen Y; Zhong J; Liu J; Liu K; Zhao J; Xu T; Zeng T; Li Z; Chen Y; Ding W; Wen G; Zu X; Cao R
Oncol Rep; 2018 Jun; 39(6):2604-2612. PubMed ID: 29620287
[TBL] [Abstract][Full Text] [Related]
4. Hwanggeumchal sorghum induces cell cycle arrest, and suppresses tumor growth and metastasis through Jak2/STAT pathways in breast cancer xenografts.
Park JH; Darvin P; Lim EJ; Joung YH; Hong DY; Park EU; Park SH; Choi SK; Moon ES; Cho BW; Park KD; Lee HK; Kim MJ; Park DS; Chung IM; Yang YM
PLoS One; 2012; 7(7):e40531. PubMed ID: 22792362
[TBL] [Abstract][Full Text] [Related]
5. PARP-1 Regulates Estrogen-Dependent Gene Expression in Estrogen Receptor α-Positive Breast Cancer Cells.
Gadad SS; Camacho CV; Malladi V; Hutti CR; Nagari A; Kraus WL
Mol Cancer Res; 2021 Oct; 19(10):1688-1698. PubMed ID: 34158394
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody against the ectodomain of E-cadherin (DECMA-1) suppresses breast carcinogenesis: involvement of the HER/PI3K/Akt/mTOR and IAP pathways.
Brouxhon SM; Kyrkanides S; Teng X; Raja V; O'Banion MK; Clarke R; Byers S; Silberfeld A; Tornos C; Ma L
Clin Cancer Res; 2013 Jun; 19(12):3234-46. PubMed ID: 23620408
[TBL] [Abstract][Full Text] [Related]
7. Tumorigenicity of MCF-7 human breast cancer cells lacking the p38α mitogen-activated protein kinase.
Mendoza RA; Moody EE; Enriquez MI; Mejia SM; Thordarson G
J Endocrinol; 2011 Jan; 208(1):11-9. PubMed ID: 20974639
[TBL] [Abstract][Full Text] [Related]
8. The Herbal Combination Shu Gan Jie Yu Regulates the SNCG/ER-a/AKT-ERK Pathway in DMBA-Induced Breast Cancer and Breast Cancer Cell Lines Based on RNA-Seq and IPA Analysis.
Zhao Y; Zhao L; Wang T; Liu Z; Tang S; Huang H; Wu L; Sun Y
Integr Cancer Ther; 2024; 23():15347354241233258. PubMed ID: 38369762
[TBL] [Abstract][Full Text] [Related]
9. Identification of a Potent Cytotoxic Pyrazole with Anti-Breast Cancer Activity That Alters Multiple Pathways.
Gutierrez DA; Contreras L; Villanueva PJ; Borrego EA; Morán-Santibañez K; Hess JD; DeJesus R; Larragoity M; Betancourt AP; Mohl JE; Robles-Escajeda E; Begum K; Roy S; Kirken RA; Varela-Ramirez A; Aguilera RJ
Cells; 2022 Jan; 11(2):. PubMed ID: 35053370
[TBL] [Abstract][Full Text] [Related]
10. Gold Nanocomplex Strongly Modulates the PI3K/Akt Pathway and Other Pathways in MCF-7 Breast Cancer Cell Line.
Mahmoud NN; Abuarqoub D; Zaza R; Sabbah DA; Khalil EA; Abu-Dahab R
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397063
[TBL] [Abstract][Full Text] [Related]
11. Multiomic profiling of breast cancer cells uncovers stress MAPK-associated sensitivity to AKT degradation.
Erickson EC; You I; Perry G; Dugourd A; Donovan KA; Crafter C; Johannes JW; Williamson S; Moss JI; Ros S; Ziegler RE; Barry ST; Fischer ES; Gray NS; Madsen RR; Toker A
Sci Signal; 2024 Feb; 17(825):eadf2670. PubMed ID: 38412255
[TBL] [Abstract][Full Text] [Related]
12. Estrogen-receptor status determines differential regulation of α1- and α2-adrenoceptor-mediated cell survival, angiogenesis, and intracellular signaling responses in breast cancer cell lines.
Priyanka HP; Pratap UP; Nair RS; Vasantharekha R; ThyagaRajan S
Med Oncol; 2024 Mar; 41(5):92. PubMed ID: 38526769
[TBL] [Abstract][Full Text] [Related]
13. The β-glucan from
Xu H; Zou S; Xu X
Oncotarget; 2017 Oct; 8(49):86693-86709. PubMed ID: 29156828
[TBL] [Abstract][Full Text] [Related]
14. Identification of a potent herbal molecule for the treatment of breast cancer.
Koduru S; Sowmyalakshmi S; Kumar R; Gomathinayagam R; Rohr J; Damodaran C
BMC Cancer; 2009 Jan; 9():41. PubMed ID: 19183448
[TBL] [Abstract][Full Text] [Related]
15. Effects of matcha tea extract on cell viability and estrogen receptor-β expression on MCF-7 breast cancer cells.
Keckstein S; Tilgener C; Jeschke U; Hofmann S; Vilsmaier T; Keilmann L; Heidegger H; Kaltofen T; Batz F; Mahner S; Schröder L
Arch Gynecol Obstet; 2024 Apr; 309(4):1509-1514. PubMed ID: 37737883
[TBL] [Abstract][Full Text] [Related]
16. Estrogenic Activity of Mycoestrogen (3
Lee D; Ko Y; Pang C; Ko YJ; Choi YK; Kim KH; Kang KS
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011267
[No Abstract] [Full Text] [Related]
17. Specific c-Jun N-Terminal Kinase Inhibitor, JNK-IN-8 Suppresses Mesenchymal Profile of PTX-Resistant MCF-7 Cells through Modulating PI3K/Akt, MAPK and Wnt Signaling Pathways.
Ozfiliz Kilbas P; Sonmez O; Uysal-Onganer P; Coker Gurkan A; Obakan Yerlikaya P; Arisan ED
Biology (Basel); 2020 Oct; 9(10):. PubMed ID: 33019717
[TBL] [Abstract][Full Text] [Related]
18. VDX-111 targets proliferative pathways in canine cancer cell lines.
Farrell KB; Das S; Nordeen SK; Lambert JR; Thamm DH
PLoS One; 2024; 19(5):e0303470. PubMed ID: 38771847
[TBL] [Abstract][Full Text] [Related]
19. Enhanced ZnR/GPR39 Activity in Breast Cancer, an Alternative Trigger of Signaling Leading to Cell Growth.
Ventura-Bixenshpaner H; Asraf H; Chakraborty M; Elkabets M; Sekler I; Taylor KM; Hershfinkel M
Sci Rep; 2018 May; 8(1):8119. PubMed ID: 29802348
[TBL] [Abstract][Full Text] [Related]
20. Investigation of Fibroblast Growth Factor Peptide Antagonist on Mouse Model Breast Tumor through ERK/MAPK and PI3K/AKT Signaling Pathways.
Ghadirian S; Tabibzadeh A; Rezvani H; Jafarzadeh M
Asian Pac J Cancer Prev; 2024 Feb; 25(2):473-483. PubMed ID: 38415533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
